Joint Biomedical Laboratory Research and Development and Clinical Science Research and Development Services Scientific Merit Review Board Notice of Meetings, 18344 [2019-08695]
Download as PDF
18344
Federal Register / Vol. 84, No. 83 / Tuesday, April 30, 2019 / Notices
Because the meeting is being held in
a government building, a photo I.D.
must be presented at the guard’s desk as
a part of the clearance process. To
prevent delays, you should allow an
additional 30 minutes before the
meeting begins to clear security. Any
member of the public seeking additional
information should contact Dr. Block,
Designated Federal Officer, at (202)
443–5600, or by email at karen.block@
va.gov.
Dated: April 25, 2019.
LaTonya L. Small,
Federal Advisory Committee Management
Officer.
Advisory Committee Act that the
subcommittees of the Joint Biomedical
Laboratory Research and Development
and Clinical Science Research and
Development Services Scientific Merit
Review Board (JBL/CS SMRB) will meet
from 8 a.m. to 5 p.m. on the dates
indicated below (unless otherwise
listed):
[FR Doc. 2019–08696 Filed 4–29–19; 8:45 am]
BILLING CODE 8320–01–P
DEPARTMENT OF VETERANS
AFFAIRS
Joint Biomedical Laboratory Research
and Development and Clinical Science
Research and Development Services
Scientific Merit Review Board Notice of
Meetings
The Department of Veterans Affairs
(VA) gives notice under Federal
Subcommittee
Date
Location
Oncology-A/D ...........................................................
Cellular & Molecular Medicine ..................................
Endocrinology-A .......................................................
Neurobiology-C .........................................................
Mental Health & Behavioral Sciences-A ..................
Oncology-B/E ............................................................
Surgery .....................................................................
Cardiovascular Studies-A .........................................
Infectious Diseases-A ...............................................
Oncology-C ...............................................................
Endocrinology-B .......................................................
Immunology & Dermatology-A .................................
Neurobiology-B .........................................................
Infectious Diseases-B ...............................................
Pulmonary Medicine .................................................
Gulf War Research ...................................................
Neurobiology-A .........................................................
Neurobiology-E .........................................................
Gastroenterology ......................................................
Nephrology ...............................................................
* Neurobiology-F .......................................................
Cardiovascular Studies-B .........................................
Epidemiology ............................................................
Mental Health & Behavioral Sciences-B ..................
Hematology ...............................................................
Neurobiology-D .........................................................
Eligibility ....................................................................
May 17, 2019 ......................................
May 20, 2019 ......................................
May 21, 2019 ......................................
May 21, 2019 ......................................
May 22, 2019 ......................................
May 22, 2019 ......................................
May 22, 2019 ......................................
May 23, 2019 ......................................
May 23, 2019 ......................................
May 23, 2019 ......................................
May 29, 2019 ......................................
May 29, 2019 ......................................
May 29, 2019 ......................................
May 30, 2019 ......................................
May 30, 2019 ......................................
May 30, 2019 ......................................
May 31, 2019 ......................................
May 31, 2019 ......................................
June 4, 2019 .......................................
June 4, 2019 .......................................
June 5, 2019 .......................................
June 6, 2019 .......................................
June 6, 2019 .......................................
June 6, 2019 .......................................
June 7, 2019 .......................................
June 7, 2019 .......................................
July 22, 2019 ......................................
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
VA Central Office.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
20 F Conference Center.
The addresses of the meeting sites are: 20 F Conference Center, 20 F Street NW, Washington, DC; VA Central Office, 1100 First Street NE,
Suite 600, Washington, DC.
amozie on DSK9F9SC42PROD with NOTICES
* Teleconference
The purpose of the subcommittees is
to provide advice on the scientific
quality, budget, safety and mission
relevance of investigator-initiated
research applications submitted for VA
merit review evaluation. Applications
submitted for review include various
medical specialties within the general
areas of biomedical, behavioral and
clinical science research.
These subcommittee meetings will be
closed to the public for the review,
discussion, and evaluation of initial and
renewal research applications, which
involve reference to staff and consultant
critiques of research applications.
Discussions will deal with scientific
VerDate Sep<11>2014
18:08 Apr 29, 2019
Jkt 247001
merit of each application and
qualifications of personnel conducting
the studies, the disclosure of which
would constitute a clearly unwarranted
release of proprietary processes and
data. Additionally, premature disclosure
of research information could
significantly obstruct implementation of
proposed agency action regarding the
research applications. As provided by
subsection 10(d) of Public Law 92–463,
as amended by Public Law 94–409,
closing the subcommittee meetings is in
accordance with Title 5 U.S.C. 552b(c)
(6) and (9)(B).
Those who would like to obtain a
copy of the minutes from the closed
PO 00000
Frm 00113
Fmt 4703
Sfmt 9990
subcommittee meetings and rosters of
the subcommittee members should
contact Holly Krull, Ph.D., Manager,
Merit Review Program (10X2B),
Department of Veterans Affairs, 810
Vermont Avenue NW, Washington, DC
20420, at (202) 632–8522 or email at
holly.krull@va.gov.
Dated: April 25, 2019.
LaTonya L. Small,
Federal Advisory Committee Management
Officer.
[FR Doc. 2019–08695 Filed 4–29–19; 8:45 am]
BILLING CODE P
E:\FR\FM\30APN1.SGM
30APN1
Agencies
[Federal Register Volume 84, Number 83 (Tuesday, April 30, 2019)]
[Notices]
[Page 18344]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-08695]
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Joint Biomedical Laboratory Research and Development and Clinical
Science Research and Development Services Scientific Merit Review Board
Notice of Meetings
The Department of Veterans Affairs (VA) gives notice under Federal
Advisory Committee Act that the subcommittees of the Joint Biomedical
Laboratory Research and Development and Clinical Science Research and
Development Services Scientific Merit Review Board (JBL/CS SMRB) will
meet from 8 a.m. to 5 p.m. on the dates indicated below (unless
otherwise listed):
------------------------------------------------------------------------
Subcommittee Date Location
------------------------------------------------------------------------
Oncology-A/D.................. May 17, 2019..... 20 F Conference
Center.
Cellular & Molecular Medicine. May 20, 2019..... 20 F Conference
Center.
Endocrinology-A............... May 21, 2019..... 20 F Conference
Center.
Neurobiology-C................ May 21, 2019..... 20 F Conference
Center.
Mental Health & Behavioral May 22, 2019..... 20 F Conference
Sciences-A. Center.
Oncology-B/E.................. May 22, 2019..... 20 F Conference
Center.
Surgery....................... May 22, 2019..... 20 F Conference
Center.
Cardiovascular Studies-A...... May 23, 2019..... 20 F Conference
Center.
Infectious Diseases-A......... May 23, 2019..... 20 F Conference
Center.
Oncology-C.................... May 23, 2019..... 20 F Conference
Center.
Endocrinology-B............... May 29, 2019..... 20 F Conference
Center.
Immunology & Dermatology-A.... May 29, 2019..... 20 F Conference
Center.
Neurobiology-B................ May 29, 2019..... 20 F Conference
Center.
Infectious Diseases-B......... May 30, 2019..... 20 F Conference
Center.
Pulmonary Medicine............ May 30, 2019..... 20 F Conference
Center.
Gulf War Research............. May 30, 2019..... 20 F Conference
Center.
Neurobiology-A................ May 31, 2019..... 20 F Conference
Center.
Neurobiology-E................ May 31, 2019..... 20 F Conference
Center.
Gastroenterology.............. June 4, 2019..... 20 F Conference
Center.
Nephrology.................... June 4, 2019..... 20 F Conference
Center.
* Neurobiology-F.............. June 5, 2019..... VA Central Office.
Cardiovascular Studies-B...... June 6, 2019..... 20 F Conference
Center.
Epidemiology.................. June 6, 2019..... 20 F Conference
Center.
Mental Health & Behavioral June 6, 2019..... 20 F Conference
Sciences-B. Center.
Hematology.................... June 7, 2019..... 20 F Conference
Center.
Neurobiology-D................ June 7, 2019..... 20 F Conference
Center.
Eligibility................... July 22, 2019.... 20 F Conference
Center.
------------------------------------------------------------------------
The addresses of the meeting sites are: 20 F Conference Center, 20 F
Street NW, Washington, DC; VA Central Office, 1100 First Street NE,
Suite 600, Washington, DC..
------------------------------------------------------------------------
* Teleconference
The purpose of the subcommittees is to provide advice on the
scientific quality, budget, safety and mission relevance of
investigator-initiated research applications submitted for VA merit
review evaluation. Applications submitted for review include various
medical specialties within the general areas of biomedical, behavioral
and clinical science research.
These subcommittee meetings will be closed to the public for the
review, discussion, and evaluation of initial and renewal research
applications, which involve reference to staff and consultant critiques
of research applications. Discussions will deal with scientific merit
of each application and qualifications of personnel conducting the
studies, the disclosure of which would constitute a clearly unwarranted
release of proprietary processes and data. Additionally, premature
disclosure of research information could significantly obstruct
implementation of proposed agency action regarding the research
applications. As provided by subsection 10(d) of Public Law 92-463, as
amended by Public Law 94-409, closing the subcommittee meetings is in
accordance with Title 5 U.S.C. 552b(c) (6) and (9)(B).
Those who would like to obtain a copy of the minutes from the
closed subcommittee meetings and rosters of the subcommittee members
should contact Holly Krull, Ph.D., Manager, Merit Review Program
(10X2B), Department of Veterans Affairs, 810 Vermont Avenue NW,
Washington, DC 20420, at (202) 632-8522 or email at [email protected].
Dated: April 25, 2019.
LaTonya L. Small,
Federal Advisory Committee Management Officer.
[FR Doc. 2019-08695 Filed 4-29-19; 8:45 am]
BILLING CODE P